← Eichor
Condition: Locally Advanced Nasopharyngeal Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Locally Advanced Nasopharyngeal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT04437329Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NA · 20 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05892354Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06055816Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Phase 2 · 1 location(s) · Chongqing University Cancer Hospital · NCT06059261Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT07085234Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cyc
Phase 3 · 1 location(s) · Fudan University · NCT05772208Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Ve
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07706985AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metasta
Phase 1/Phase 2 · 18 location(s) · Avenzo Therapeutics, Inc. · NCT07038343GNT Induction Treatment in Locally Advanced NPC
Phase 3 · 1 location(s) · Air Force Military Medical University, China · NCT06026878A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,
Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06475300Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · First Affiliated Hospital, Sun Yat-Sen University · NCT05860868A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nas
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07392320Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Stu
Phase 2 · 1 location(s) · Sichuan Cancer Hospital and Research Institute · NCT05508347The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
Phase N/A · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT06182657Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinom
Phase 3 · 12 location(s) · Ming-Yuan Chen · NCT07328841Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
Phase 3 · 1 location(s) · Man Hu · NCT07340515Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA A
Phase 3 · 1 location(s) · Fudan University · NCT05674305Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05397769A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
Phase 1 · 8 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05194982Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Yonsei University · NCT04910347Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07496190Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04136886A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Phase 2 · 1 location(s) · Fudan University · NCT05628922VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · 15 location(s) · VM Oncology, LLC · NCT03556228GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06851247PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NP
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07332247A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Naso
Phase 2 · 16 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05956587ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · First Affiliated Hospital, Sun Yat-Sen University · NCT05062005Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal C
Phase 2 · 4 location(s) · Sun Yat-sen University · NCT07362979
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.